The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women
NCT ID: NCT01381588
Last Updated: 2017-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1136 participants
OBSERVATIONAL
2010-10-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Osteoporotic Fractures on Work: Data From a Fracture Liaisons Service
NCT04781556
Characteristics and Outcomes of Odontoid Fragility Fractures in Elderly
NCT02800278
Evaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital
NCT02924545
The Construction of Bidirectional Column Study of Acute Osteoporotic Vertebral Compression Fractures
NCT06586996
How Vertebral Fractures Effect Balance In Postmenopausal Women
NCT06502301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post menopausal women
Post menopausal women between 50 to 80
Fracture evaluation
DEXA(Dual-energy X-ray absorptiometry), X-ray
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fracture evaluation
DEXA(Dual-energy X-ray absorptiometry), X-ray
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects over 50 years old
* The Definition of Post Menopause Women : Women whose last menstruation was over 12months ago
* Subjects who visit orthopedic surgery
* Subjects who have informed consents
Exclusion Criteria
* Subjects who do not understand the contents of questionnaire
* Subjects over 80 years old
* Subjects experienced any high energy fracture (including trash and fall) within 3 months.
* Subjects experienced a fracture except vertebral fracture within 6 months
* Unable to evaluate L-spine BMD over 2 levels because of spinal fracture or instrumentation for L-spine 1-4.
* Unable to evaluate BMD at both femur because of hip fracture or instrumentation.
50 Years
79 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
114777
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.